Symbiotic Use in Post-Bariatric Surgery Patients
NCT06252558
Summary
The purpose of this double blind, randomized control trial would be to test the efficacy of a once daily, multi strain symbiotic on gut health changes in weight loss surgery patients by testing stool samples prior to administration and then three months post administration of the symbiotic to monitor any changes in bacteria in the stool samples. Study participants will also complete a survey that evaluates their bowel habits, stool consistency, and gastrointestinal related symptoms.
Eligibility
Inclusion Criteria: * 12 months or greater post malabsorptive weight loss procedure Exclusion Criteria: * LapBand or Intra-gastric balloon patients due to lack of surgical alteration to gut * Individuals who have not had an approved weight loss procedure * Individuals with impaired gastrointestinal function which would impair ingestion of oral supplement * Individuals with impaired gastrointestinal function which would impair ability to collect stool sample * Inability to comprehend and complete assessment tools * Inability to adhere to 90-day capsule supplement administration * Currently taking daily probiotic, prebiotic, or symbiotic supplement * Currently taking antibiotic treatment from physician
Conditions2
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06252558